Terms: = Head and neck cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1 AND Treatment
728 results:
1. Gender Difference in sidE eFfects of ImmuNotherapy: a possible clue to optimize cancer treatment (G-DEFINER): study protocol of an observational prospective multicenter study.
Miceli R; Eriksson H; Lo Russo G; Alfieri S; Moksnes Bjaanæs M; Pietrantonio F; De Cecco L; Prelaj A; Proto C; Franzén J; McDonnell D; Berenguer Pina JJ; Beninato T; Mazzeo L; Giannatempo P; Verzoni E; Crown J; Helland Å; Eustace A
Acta Oncol; 2024 Apr; 63():213-219. PubMed ID: 38647024
[TBL] [Abstract] [Full Text] [Related]
2. Protocol of a pilot randomized clinical trial to evaluate nutritional support and rehabilitation on prevention of skeletal muscle mass loss during neoadjuvant chemotherapy in patients with esophageal cancer.
Miki Y; Nishi S; Tamura T; Imai T; Nambara M; Fukuoka T; Yoshii M; Toyokawa T; Lee S; Fujii H; Yoshida H; Ikebuchi M; Maeda K
PLoS One; 2024; 19(4):e0302003. PubMed ID: 38635741
[TBL] [Abstract] [Full Text] [Related]
3. Citalopram, an antipsychotic agent, induces G1/G0 phase cell cycle arrest and promotes apoptosis in human laryngeal carcinoma HEP-2 cells.
Salama M; Ali A; Ibrahim FAR; Elabd S
Med Oncol; 2024 Apr; 41(5):105. PubMed ID: 38573558
[TBL] [Abstract] [Full Text] [Related]
4. Second radioiodine treatment in patients with differentiated thyroid carcinoma: Causes and effects.
Sicilia Pozo MLN; Pena Pardo FJ; Amo Salas M; Cruz Montijano M; Torres Hernández J; Padilla Bermejo A; Montalbán Méndez C; Zhao Montero M; Soriano Castrejón Á; García Vicente AM
Endocrinol Diabetes Nutr (Engl Ed); 2024 Jan; 71(1):4-11. PubMed ID: 38388076
[TBL] [Abstract] [Full Text] [Related]
5. Very high-energy electron therapy as light-particle alternative to transmission proton FLASH therapy - An evaluation of dosimetric performances.
Böhlen TT; Germond JF; Desorgher L; Veres I; Bratel A; Landström E; Engwall E; Herrera FG; Ozsahin EM; Bourhis J; Bochud F; Moeckli R
Radiother Oncol; 2024 May; 194():110177. PubMed ID: 38378075
[TBL] [Abstract] [Full Text] [Related]
6. Adherence and impact of an oral nutritional supplement enriched in leucine, EVOO, EPA and DHA, and beta-glucans on the coverage of energy and protein requirements in patients with cancer and malnutrition: Alisenoc study.
Milla SP; Luna PPG; Casariego AV; González FV; Folgueras TM; Jáuregui OI; Rey SG; Fernández AC; Plaza BL; Quintana TC; de Luis Román DA
Nutrition; 2024 Apr; 120():112355. PubMed ID: 38341907
[TBL] [Abstract] [Full Text] [Related]
7. Efficacy and safety of pralsetinib in Chinese advanced RET-mutant medullary thyroid cancer patients.
Zheng X; Fang M; Fan Y; Sun Y; Sun M; Yang A; Zhang B; Liu Q; Liu H; Zhou X; Huang T; Qin J; Wang Z; Qin M; Shen Z; Yao S; Yang J; Wang Y; Gao M
Endocr Relat Cancer; 2024 Apr; 31(4):. PubMed ID: 38261313
[TBL] [Abstract] [Full Text] [Related]
8. Metabolomic Insight into Implications of Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Locally Advanced head and neck cancer.
Boguszewicz Ł; Bieleń A; Ciszek M; Skorupa A; Mrochem-Kwarciak J; Składowski K; Sokół M
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203359
[TBL] [Abstract] [Full Text] [Related]
9. Pretreatment Fibrinogen Level Is a Prognostic Factor for Esophageal cancer Patients Who Receive Curative treatment.
Aoyama T; Kato A; Hashimoto I; Maezawa Y; Hara K; Kawahara S; Kazama K; Komori K; Yoshizawa S; Tamagawa A; Tateishi M; Minami T; Cho H; Morita J; Otani K; Sawazaki S; Numata M; Tanabe M; Oshima T; Saito A; Yukawa N; Rino Y
Anticancer Res; 2024 Jan; 44(1):249-255. PubMed ID: 38159985
[TBL] [Abstract] [Full Text] [Related]
10. Statin use reduces radiation-induced stroke risk in advanced nasopharyngeal carcinoma patients.
Lin CY; Chang CL; Lin KC; Chen WM; Shia BC; Kuo PH; Wu SY
Radiother Oncol; 2024 Feb; 191():110067. PubMed ID: 38142934
[TBL] [Abstract] [Full Text] [Related]
11. Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study.
Shitara K; Rha SY; Wyrwicz LS; Oshima T; Karaseva N; Osipov M; Yasui H; Yabusaki H; Afanasyev S; Park YK; Al-Batran SE; Yoshikawa T; Yanez P; Dib Bartolomeo M; Lonardi S; Tabernero J; Van Cutsem E; Janjigian YY; Oh DY; Xu J; Fang X; Shih CS; Bhagia P; Bang YJ;
Lancet Oncol; 2024 Feb; 25(2):212-224. PubMed ID: 38134948
[TBL] [Abstract] [Full Text] [Related]
12. Protective Effect of Alpha-Linolenic Acid on Human Oral Squamous Cell Carcinoma Metastasis and Apoptotic Cell Death.
Su CC; Yu CC; Shih YW; Liu KL; Chen HW; Wu CC; Yang YC; Yeh EL; Li CC
Nutrients; 2023 Dec; 15(23):. PubMed ID: 38068849
[TBL] [Abstract] [Full Text] [Related]
13. The effect of cisplatin-based chemotherapy on hearing loss (the frequency of >8 kHz) in children with cancer.
Zand V; Mandegari M; Baradaranfar M; Vaziribozorg S; Shahzeidi A
Am J Otolaryngol; 2024; 45(2):104127. PubMed ID: 38061174
[TBL] [Abstract] [Full Text] [Related]
14. Protocol for the EACH trial: a multicentre phase II study evaluating the safety and antitumour activity of the combination of avelumab, an anti-PD-L1 agent, and cetuximab, as any line treatment for patients with recurrent/metastatic head and neck squamous cell cancer (HNSCC) in the UK.
Ng K; Metcalf R; Sacco J; Kong A; Wheeler G; Forsyth S; Bhat R; Ward J; Ensell L; Lowe H; Spanswick V; Hartley J; White L; Lloyd-Dehler E; Forster M
BMJ Open; 2023 Nov; 13(11):e070391. PubMed ID: 38011968
[TBL] [Abstract] [Full Text] [Related]
15. Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid cancer: Updated Efficacy and Safety Data from the ARROW Study.
Subbiah V; Hu MI; Mansfield AS; Taylor MH; Schuler M; Zhu VW; Hadoux J; Curigliano G; Wirth L; Gainor JF; Alonso G; Adkins D; Godbert Y; Ahn MJ; Cassier PA; Cho BC; Lin CC; Zalutskaya A; Barata T; Trask P; Scalori A; Bordogna W; Heinzmann S; Brose MS
Thyroid; 2024 Jan; 34(1):26-40. PubMed ID: 38009200
[No Abstract] [Full Text] [Related]
16. Survival of Patients With head and neck Merkel Cell cancer: Findings From the Pan-Canadian Merkel Cell cancer Collaborative.
Nayak AL; Pickett AT; Delisle M; Dingley B; Mallick R; Hamilton T; Stuart H; Talbot M; McKinnon G; Jost E; Thiboutot E; Francescutti V; Samman S; Easson A; Schellenberg A; Merchant S; La J; Vanderbeck K; Wright F; Berger-Richardson D; Hebbard P; Hershorn O; Younan R; Patocskai E; Rodriguez-Qizilbash S; Meguerditichian A; Tchuente V; Kazandjian S; Mathieson A; Hossain F; Hetu J; Corsten M; Tohmé A; Nessim C; Johnson-Obaseki S
JAMA Netw Open; 2023 Nov; 6(11):e2344127. PubMed ID: 37983027
[TBL] [Abstract] [Full Text] [Related]
17. [Clinical analysis of retropharyngeal lymph node metastasis in patients with hypopharyngeal squamous cell carcinoma].
Feng SH; Lyu ZH; Ma JK; Liu SF; Yu XW; Wei YM; Jing PH; Liu XL; Zhou C; Sa N; Xu W
Zhonghua Zhong Liu Za Zhi; 2023 Nov; 45(11):955-961. PubMed ID: 37968081
[No Abstract] [Full Text] [Related]
18. Novel approach of prophylactic radiation to reduce toxicities comparing 2-step40 with 56-Gy simultaneous integrated boost intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the head and neck, an intergroup phase III trial (JCOG1912, NEW BRIDGE).
Yokota T; Zenda S; Kodaira T; Kiyota N; Fujimoto Y; Wasano K; Takahashi R; Mizowaki T; Homma A; Sasaki K; Machida R; Sekino Y; Fukuda H; ;
BMC Cancer; 2023 Nov; 23(1):1068. PubMed ID: 37932681
[TBL] [Abstract] [Full Text] [Related]
19. Age-stratified comparison of active surveillance versus radiofrequency ablation for papillary thyroid microcarcinoma using decision analysis.
Carlisle KM; Brown JP; Kim J; Turner DJ; Slejko JF; Kuo JH; Mullins CD; Hu Y
Surgery; 2024 Jan; 175(1):153-160. PubMed ID: 37872047
[TBL] [Abstract] [Full Text] [Related]
20. Effects of Ultrasound-Guided Laser Ablation Therapy on Symptomatic Benign Thyroid Nodules, Using EchoLaser - Results of a Pilot Study in the United States.
Thomas J; Ledger GA; Haertling T
Endocr Pract; 2023 Dec; 29(12):942-947. PubMed ID: 37704167
[TBL] [Abstract] [Full Text] [Related]
[Next]
